Continuous or Batch: Deciding on the Best Solution for your Oral Solid Dose Product

Continuous or Batch: Deciding on the Best Solution for your Oral Solid Dose Product

Continuous manufacturing enables the development of a more diverse pipeline of drug products by greater quality assurance, reduced API usage, and timeline efficiencies. It also reduces scale up activities as a product increases in volume in the clinical phase through commercial. With that comes the benefits of reduced API usage, and therefore costs. Additional benefits include timeline efficiencies as well as a reduction of technical risks, as continuous manufacturing systems are designed with integrated solutions that allow for real-time analysis and control.

Resource Library

Related Sites

Additional Resources

Hot melt extrusion: Improving solubility of poorly soluble compounds

Manufacturing Process Scale-up for Phase III: Clear Sailing or Storms Ahead?

Manufacturing Innovation: The Case for Continuous Manufacturing

Navigating Decision Points to Fast-Track Commercialisation

Setting a strong foundation for your oral solid dose product to support late-stage development

How overcoming barriers ensured on-time delivery of a life-changing medication

Global steriles investment & innovation

Steriles Drug Development & Manufacturing: Flexibility and Optimization

Oral solid dose - Access a range of flexible drug development & manufacturing solutions

Orphan Drugs: Balancing Financial Incentives & Complex Challenges

Navigating the Adoption of Continuous Manufacturing Amid Unprecedented Global Challenges

Impact of a Pandemic Outbreak on Vaccine Development Approach

Validation or Qualification - What's the difference?

Evaluate Impact of Spray Drying Process Parameters and Equipment Type on the Granule Characteristic of the Immediate Release Tablets of a BCS (Biopharmaceutical Classification System) Class–IV Drug

Hot Melt Extrusion Process Optimization and Formulation Development of Amorphous Solid Dispersions for a Poorly Soluble Calcium Channel Blocker

Lyophilization: Small-Large Scale Comparability

To Determine the Dosing Disk and Encapsulation Speed for Encapsulation of a Drug Product Using Automated Encapsulator

A Quality by Design Approach to Optimize Tablet Formulations containing PVP VA64 Amorphous Dispersions: Formulation Variables

Discrete Element Modeling of a Pharmaceutical Blending Process

Accelerated stability assessment for an oral N-type calcium channel blocker

Evaluation of a Quality by Design (QbD) Approach for Process Development and Scale-Up of a Novel ALS Drug Product

Enhanced Solubilization of an Analgesic/Antipyretic Drug With The Use of Polymeric Excipients

Controlled Release of an OTC Cough Suppressant in a Soft Gelatin Based Dosage Form

Development of a High Shear Wet Granulation Process Through the Use of Design of Experiments

Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral/Injectable Delivery

Using Quality By Design For Process Development And Scale-Up Of A Novel ALS Drug Product

Quick to Clinic™ for Oral Solid Dose

Continuous Manufacturing: The Alternative to Batch Manufacturing

Quadrant 2 ®: Predictive Platform for Solubility and Bioavailability Enhancement

Common Softgel Myths Debunked

Challenges and Practical Solutions for Changing Over to Pre-filled Syringes for Parenteral Drug

Continuous Manufacturing: Drug Development Workflow and Benefits

Continuous or Batch: Deciding on the Best Solution for your Oral Solid Dose Product

Telltale Signs You're with the Wrong CDMO

Quick to Clinic for Oral Solid Dose

How Pacira Pharma Is Working To Help Curb The Opioid Epidemic

Collegium Pharmaceutical’s Approach to Abuse Deterrence Breaks New Ground

Fighting The Opioid Epidemic: How Grünenthal’s Abuse-Deterrent Technology Contributes

Flexible Solutions to Speed Your Molecules to Phase I Clinical Trials

Novel Uses for Oral Solid Doses Driving Lifecycle Management Strategies

Biologics Overview: Flexible Biomanufacturing Solutions

So Many Choices: What’s the Right Biomanufacturing Strategy for Me?

Case Study: Curbing the Opioid Epidemic with Pacira Pharmaceuticals

Technology Transfers: Reaping Rewards, Reducing Risks

Decision Timeline: Considerations in Selecting an Outsourced Solution

How Adaptable Manufacturing Models are Paving a Steady Path into an Unpredictable Future

Top 5 Considerations When Looking to Outsource to a Biomanufacturing Partner

Solving the OOS Problem with Continuous Manufacturing

Impact of Incorrect Forecasts on New Product Launches

Executive Research: Impact of Incorrect Forecasts on New Product Launches

Early Stage Development for Solid Dose Products

Built To Fail: How Today's Manufacturing Options Leave Pharma At Risk

© 2021 Thermo Fisher Scientific Inc. All rights reserved. Cookie Use Privacy Terms of Use Modern Slavery Statement

Cookie Use Privacy Terms of Use Modern Slavery Statement

© 2021 Thermo Fisher Scientific Inc. All rights reserved.